Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism

Melanoma cells are resistant to most anticancer chemotherapeutics. Despite poor response rates and short-term efficacy, chemotherapy remains the main approach to treating this cancer. The underlying mechanisms of the intrinsic chemoresistance of melanoma remain unclear, but elucidating these mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Dastych, Jarosław, Ratajewski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126047/
https://www.ncbi.nlm.nih.gov/pubmed/34068624
http://dx.doi.org/10.3390/ijms22095034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126047/
https://www.ncbi.nlm.nih.gov/pubmed/34068624
http://dx.doi.org/10.3390/ijms22095034

Ejemplares similares